Events2Join
After 40 Years a New TB Drug is Approved

After 40 Years a New TB Drug is Approved

After 40 years, new medicine for combating TB - PMC

On December 31, 2012, the FDA approved the first new tuberculosis drug in four decades. SIRTURO™ (bedaquiline) was approved on the basis of phase two ...

After 40 Years a New TB Drug is Approved | Taconic Biosciences

FDA Approves New Treatment for Highly Drug-Resistant Forms of Tuberculosis. “FDA approval of this treatment represents a victory for the people suffering from ...

Bedaquiline: First FDA-approved tuberculosis drug in 40 years - PMC

The US Food and Drug Administration (FDA) on 28 December 2012 granted accelerated approval to Johnson and Johnson's drug bedaquiline to treat resistant ...

First novel anti-tuberculosis drug in 40 years | Nature Biotechnology

On the last day of 2012, the US Food and Drug Administration (FDA) approved a new drug to treat tuberculosis—the first anti-mycobacterial ...

FDA Approves New Treatment for Highly Drug-Resistant Forms of ...

Pretomanid is only the third new anti-TB drug approved for use by FDA in more than 40 years, as well as the first to be developed and registered ...

CDC Releases Interim Guidance on a Four-Month TB Treatment ...

The new 4-month rifapentine-moxifloxacin regimen is a daily treatment option for people 12 years of age and older with drug-susceptible pulmonary TB disease in ...

Researchers reveal why a key tuberculosis drug works against ...

Approved in 2012 by the U.S. Food and Drug Administration (FDA), bedaquiline was the first new TB drug in more than 40 years. It works well ...

FDA approves breakthrough drug to treat Extensively Drug ...

Pretomanid is only the third anti-TB drug approved by the FDA in more than 40 years. Prior to the pivotal Nix-TB trial of pretomanid as part of ...

Tuberculosis

Our MDR-TB medicine is granted accelerated approval by the U.S. FDA as the first targeted drug with a novel mechanism of action against TB in more than 40 years ...

New tuberculosis drug first to hit market in 40 years - CBS News

The FDA on Monday approved a Johnson & Johnson tuberculosis pill called Sirturo for use with older drugs to fight a hard-to-treat strain of ...

A new treatment - Annual Report 2019 | TB Alliance

On August 14, 2019, TB Alliance received approval from the US Food and Drug Administration (FDA) for its anti-TB drug pretomanid in a combination regimen.

New tuberculosis drug leads from naturally occurring compounds

Bedaquiline (marketed as Sirturo) is a novel diarylquinolone that is the first new TB drug approved for use in over 40 years. Unlike the fluoroquinolones, ...

Key Moments in the History of Tuberculosis Treatment and Innovation

The FDA Grants the Treatment Accelerated Approval. The first medicine for TB in more than 40 years with a novel mechanism of action receives ...

First TB drug in 40 years approved in the USA - PharmaTimes

Regulators in the USA have granted accelerated approval of the first new tuberculosis treatment in 40 years, with the thumbs up to Janssen's ...

A new era for treatment of drug-resistant tuberculosis

Consequently, drug-resistant TB treatment takes 2 years to complete and has been associated with frequent and severe side-effects. Treatment outcomes remain ...

Impact on Industry: Critical Path to TB Drug Regimens

The collaborative work of the CPTR Initiative has contributed to the development of the first new drugs for TB in over 40 years, and has solidified a drug ...

F.D.A. Approves Sirturo, a New Tuberculosis Drug

Paul Stoffels, the chief scientific officer at Johnson & Johnson, said in an interview. He said the approval was the first time in 40 years that ...

Regimens to treat multidrug-resistant tuberculosis: past, present and ...

After over 40 years of neglect, two new drugs (bedaquiline and delamanid) have been made available to manage difficult-to-treat MDR-/XDR-TB cases. World ...

After 40 years, new medicine for combating TB. - Europe PMC

Clearly, further studies are required to determine the role of bedaquiline in TB management. As a condition of submission under accelerated FDA approval, ...

Bedaquiline: what might the future hold? - The Lancet Microbe

Bedaquiline-containing regimens, now the first-line therapy recommended by WHO, have transformed the treatment of drug-resistant tuberculosis, ...